| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/08/2003 | EP1272510A2 Pharmacologically active antiviral peptides and methods of their use |
| 01/08/2003 | EP1272509A2 Prion-binding peptidic ligands and methods of using same |
| 01/08/2003 | EP1272500A2 Process for preparing 6-o-alkenyl-subsituted erythromycin derivatives |
| 01/08/2003 | EP1272488A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 01/08/2003 | EP1272485A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272479A2 Novel compounds for enhancing chemotherapy |
| 01/08/2003 | EP1272470A1 Amorphous torasemide modification |
| 01/08/2003 | EP1272459A1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 01/08/2003 | EP1272455A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 01/08/2003 | EP1272223A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 01/08/2003 | EP1272222A2 Compositions for drug delivery |
| 01/08/2003 | EP1272221A2 Peptide conjugates for drug delivery |
| 01/08/2003 | EP1272216A2 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias |
| 01/08/2003 | EP1272215A2 Pharmaceutical preparations comprising modified peptides |
| 01/08/2003 | EP1272201A2 Use of compatible solutes as substances having free radical scavenging properties |
| 01/08/2003 | EP1272198A1 Use of organophosphorous compounds for producing a medicament for treating infections |
| 01/08/2003 | EP1272184A2 Pharmaceutical compositions comprising salmeterol and ipratropium |
| 01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
| 01/08/2003 | EP1272169A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 01/08/2003 | EP1021404B1 Azetidinone derivatives for the treatment of hcmv infections |
| 01/08/2003 | EP0966511B1 Washing disinfectant for hygienic and surgical hand disinfection |
| 01/08/2003 | EP0906107B1 Compositions comprising vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 01/08/2003 | EP0892795B1 Piperidinylpyramidine derivatives |
| 01/08/2003 | CN1390256A Novel protein and DNA thereof |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/08/2003 | CN1390220A Kinase inhibitors as therapeutic agents |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390211A Benzoic ester comprising ethoxyl acyl piperazine substituted oxazolidone compound |
| 01/08/2003 | CN1390210A Process for preparing oxazolines from tetrahydrofurans |
| 01/08/2003 | CN1390209A Use of benzotriazole UV absorbers |
| 01/08/2003 | CN1390203A Novel 5-pyrimidine carboxamide derivatives and the pharmaceutical compositions containing said derivatives |
| 01/08/2003 | CN1390201A Cyclic amine compounds as CCR5-antagonists |
| 01/08/2003 | CN1390136A Vaccine against nepatitis B virus and human papilloma virus |
| 01/08/2003 | CN1390135A Topical treatment of streptococcal infections |
| 01/08/2003 | CN1390134A The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 01/08/2003 | CN1390127A Antifungal oral composition containing itraconazole and process for preparing same |
| 01/08/2003 | CN1390122A Tissue factor antagonists and methods of use thereof |
| 01/08/2003 | CN1390118A Dextrose and insulin fluid formulation for intravenous infusion |
| 01/08/2003 | CN1389258A Quick-acting health herb tea |
| 01/08/2003 | CN1389249A Chinese medicine with five functions of resisting bacterium, diminishing inflammation, relieving cough, relieving asthma and eliminating phlegm |
| 01/08/2003 | CN1389242A 白茅根茶 Imperatae tea |
| 01/08/2003 | CN1389241A Composite medicine for treating hircus, tinea and external piles |
| 01/08/2003 | CN1389231A Composite Chinese medicine for treating venereal disease and dermatosis and its prepn. |
| 01/08/2003 | CN1389212A Bupleurum flavone composition for resisiting influenza virus and its prepn. |
| 01/08/2003 | CN1389209A Myocarditis treating medicine |
| 01/08/2003 | CN1389204A Chinese medicine extract for treating hepatitis and its prepn. |
| 01/08/2003 | CN1098274C AZA cyclohexapeptide compounds |
| 01/08/2003 | CN1098266C Fused pyrrolo (2,3-c) carbazole-6-one which potentiate activity of gamma interferon |
| 01/08/2003 | CN1098260C 2,4-diaminopyrimidine derivatives |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098249C Use of ubimec or medicinal composition containing ubimec for treatment virus hepatitis |
| 01/08/2003 | CN1098104C New oral pharmaceutical dosage form |
| 01/08/2003 | CN1098103C Pharmaceutical use of sympathetic human white-cell interferon |
| 01/08/2003 | CN1098082C Pudenda cleaning liquid and its production process and application |
| 01/08/2003 | CN1098080C Ear drops |
| 01/08/2003 | CN1098078C Composition for preventing and treating bacterial diseases of young chicken |
| 01/08/2003 | CN1098076C Broad-spectrum antifungal oral medicine for treating skin soft tissue infection and syphilitic clap |
| 01/08/2003 | CN1098075C Broad-spectrum antibacterial medicine and its exterior application method |
| 01/08/2003 | CN1098070C Guanylhydrazones for treating inflammatory conditions |
| 01/07/2003 | US6504035 3-deoxy-desmycosin derivatives and process for their preparation |
| 01/07/2003 | US6504027 Decarboxylation process for synthesizing carbapenem antibiotics |
| 01/07/2003 | US6504026 Process for production of ceftiofur |
| 01/07/2003 | US6504025 In fewer steps and is obtained in higher yield; chemical intermediates; useful in treating methicillin resistent Staphylococcus aureus and Pseudomonas aeruginosa |
| 01/07/2003 | US6504020 Isolated nucleic acids comprising Listeria dal and dat genes |
| 01/07/2003 | US6504017 Erthromycin a oxime solvates |
| 01/07/2003 | US6504005 Long-acting drugs and pharmaceutical compositions comprising them |
| 01/07/2003 | US6503946 Preparation for warts |
| 01/07/2003 | US6503940 Prodrugs for antimicrobial amidines |
| 01/07/2003 | US6503934 Substituted thiadiazolesulfonamides |
| 01/07/2003 | US6503923 Haloalkoxy imidazonaphthyridines |
| 01/07/2003 | US6503914 Thienopyrimidine-based inhibitors of the Src family |
| 01/07/2003 | US6503907 Indole and dihydroindole derivatives |
| 01/07/2003 | US6503903 Fab I inhibitors |
| 01/07/2003 | US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection |
| 01/07/2003 | US6503897 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria |
| 01/07/2003 | US6503890 Aryl phosphate derivatives of d4T having anti-HIV activity |
| 01/07/2003 | US6503882 Treatment of HIV |
| 01/07/2003 | US6503881 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503539 Matrix protein compositions for wound healing |
| 01/07/2003 | US6503533 Antisense ogligonucleotides against Hepatitis B viral replication |
| 01/07/2003 | US6503514 Attenuated strains of mycobacteria |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | US6503512 Anti-AIDS immunomodulator complex |
| 01/07/2003 | US6503511 Derivatives of choline binding proteins for vaccines |
| 01/07/2003 | US6503507 Oxygen activatable formulations for disinfection or sterilization |
| 01/07/2003 | US6503505 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/07/2003 | CA2093825C Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| 01/07/2003 | CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003000922A2 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | WO2003000899A1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000869A1 Transgenic animals and cells expressing proteins necessary for susceptibility to hiv infection |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |